Chief Executive Officer
Wed, Feb 19, 2020
Feb 19
exercised or converted securities in APLS
30,637 shares @ $0.00
Decreased holdings by -33.30%
Net across this filing: +2.50% (+25,637 shares)
Option Exercise
Sale tied to a same-time option exercise
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology